Domestic family violence (FV) is a serious problem with serious impacts on mental health of victims. One such impact is post-traumatic stress disorder (PTSD), and it can be resistant to treatment (treatment-resistant or TR). This article offers novel treatment.
Methods:
Two treatment resistant case studies are described where adjunctive treatment with brexpiprazole was commenced. Possible theoretical considerations are presented to explain improvement.
Results:
Adjunctive treatment with brexpiprazole was associated with significant improvement in FV subjective and objective measures, with enhanced response to trauma therapy.
Conclusion:
Brexpiprazole improved complex post traumatic stress disorder in FV victims and needs further evaluation.
World Health Organization (WHO), London School of Hygiene and Tropical Medicine. Preventing intimate partner and sexual violence against women and taking actions and generating evidence. Geneva (CH): WHO, 2010.
TrevillionKOramSFederG, et alExperiences of domestic violence and mental disorders: a systematic review and meta-analysis. PLoS One2012; 7: e51740.
4.
O’ConnorMIbrahimS. Suicidality and family violence in Australian immigrant women presenting to out-patient mental health settings. Australas Psychiatry2018; 26: 224–225.
5.
ReesSSiloveDCheyT, et alLifetime prevalence of gender-based violence in women and the relationship with mental disorders and psychosocial function. JAMA2011; 306: 513–521.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: Author, 2013.
8.
DunlopBWKayeJLYoungnerC, et alAssessing treatment-resistant posttraumatic stress disorder: the emory treatment resistance interview for PTSD (E-TRIP). Behav Sci (Basel)2014; 4: 511–527.
9.
DetweilerMBPagadalaBCandelarioJ, et alTreatment of post-traumatic stress disorder nightmares at a veterans affairs medical center. J Clin Med2016; 5: 117.
10.
KhazaieHGhadamiMRMasoudiM. Sleep disturbances in veterans with chronic war-induced PTSD. J Inj Violence Res2016; 8: 99–107.
11.
HopeJCastleDKeksN. Brexpiprazole: a new leaf on the partial dopamine agonist branch. Australas Psychiatry2018; 26: 92–94.
12.
Otsuka Pharmaceutical Co., Ltd. Otsuka and Lundbeck report positive phase II data for the combination treatment of brexpiprazole and sertraline for the treatment of Post-Traumatic Stress Disorder (PTSD). 30November2018.
CohenHZoharJKaplanZ, et alAdjunctive treatment with brexpiprazole and escitalopram reduces behavioural stress responses and increase hypothalamic NPY immunoreactivity in a rat model of PTSD-like symptoms. European Neuropsychopharmacol2018; 28: 63–74.
15.
HamnerMBDiamondBI. Elevated plasma dopamine in posttraumatic stress disorder: a preliminary report. Biol Psychiatry1993; 33: 304–306.
16.
KapurS. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry2003; 160: 13–23.
17.
World Health Organization. International Classification of Diseases for Mortality and Morbidity Statistics Eleventh Revision. https://icd.who.int/icd11refguide/en/index.html (2019, accessed 6 December 2019).
